SIREN : 530586726
HOME MEDICAL PARTNER is a French company founded 15 years ago, specialized in the sector Activités des sociétés holding. Based in SOLLIES-PONT (83210), this company of category PME shows in 2017 a revenue of 879€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | N/C | N/C | 879 € |
| Net income | 19 973 € | 13 876 € | 214 € | 8 674 € | 51 973 € | 265 308 € | 20 234 € |
| EBITDA | N/C | 2 300 € | -3 015 € | 2 300 € | -2 695 € | -4 834 € | -13 146 € |
| Net margin | N/C | N/C | N/C | N/C | N/C | N/C | 2301.9% |
In 2023, HOME MEDICAL PARTNER generates positive net income of 20 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 20 k€ -> 20 k€.
19 973 €
The debt ratio (= Financial debt / Equity x 100) stands at 24%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
24.362%
68.786%
In 2023, the debt ratio of HOME MEDICAL PARTNER (24.36) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of HOME MEDICAL PARTNER (68.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2022, the repayment capacity of HOME MEDICAL PARTNER (12.65) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 63 transactions of similar company sales
in 2023,
the value of HOME MEDICAL PARTNER is estimated at
186 304 €
(range 33 962€ - 276 459€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 63 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HOME MEDICAL PARTNER with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of HOME MEDICAL PARTNER in 2017 is 879€.
Yes, HOME MEDICAL PARTNER generated a net profit of 20 k€ in 2023.
The headquarters of HOME MEDICAL PARTNER is located in SOLLIES-PONT (83210), in the department Var.
The tax return of HOME MEDICAL PARTNER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HOME MEDICAL PARTNER operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.